Hodgkin disease survival in Europe and the U.S.

The survival of patients with Hodgkin disease (HD) varies markedly across Europe and generally is shorter than the survival of patients in the U.S. To investigate these differences, the authors compared population‐based HD survival in relation to morphologic type among populations in Europe and the U.S.

[1]  R. Tsang,et al.  Hodgkin’s lymphoma , 2018, Concise Notes in Oncology for MRCP and MRCS.

[2]  H. Eich,et al.  Role of hematotoxicity and sex in patients with Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  H. Eich,et al.  Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  J. Coebergh,et al.  Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven Cancer Registry. , 2005, European journal of cancer.

[5]  Paul W Dickman,et al.  Regression models for relative survival , 2004, Statistics in medicine.

[6]  S. Glaser,et al.  Age-specific survival after Hodgkin's disease in a population-based cohort (United States) , 2001, Cancer Causes & Control.

[7]  M. Coleman,et al.  Survival of cancer patients in europe—The EUROCARE study , 1995, Cancer Causes & Control.

[8]  C. Franceschi,et al.  The immune system in the elderly , 2004, Immunologic research.

[9]  A. Levis,et al.  VEPEMB in elderly Hodgkin's lymphoma patients. Results from an Intergruppo Italiano Linfomi (IIL) study. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  F Berrino,et al.  EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  H. Geys,et al.  Trend of cervical cancer mortality in Belgium (1954–1994): Tentative solution for the certification problem of unspecified uterine cancer , 2002, International journal of cancer.

[12]  S. Glaser,et al.  Expert review of the diagnosis and histologic classification of Hodgkin disease in a population‐based cancer registry , 2001, Cancer.

[13]  F. Berrino,et al.  Cancer survival in Britain , 1999, BMJ.

[14]  V. Diehl,et al.  Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  J. Armitage,et al.  A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. , 1998, The New England journal of medicine.

[16]  D. Hendrick,et al.  Age-dependent inaccuracy of asthma death certification in Northern England, 1991-1992. , 1998, The European respiratory journal.

[17]  D. Wright,et al.  Epstein–Barr virus and Hodgkin’s disease: further evidence for the three disease hypothesis , 1998, Leukemia.

[18]  E. Bessell,et al.  Hodgkin's disease in patients older than 70 years of age: a registry-based analysis. , 1997, European journal of cancer.

[19]  J. Coebergh,et al.  Improved survival of Hodgkin's patients in south-east Netherlands since 1972. , 1997, European journal of cancer.

[20]  G. Maudsley,et al.  "Inaccuracy' in death certification--where are we now? , 1996, Journal of public health medicine.

[21]  F. Erdkamp,et al.  Hodgkin disease in the elderly. A registry‐based analysis , 1992, Cancer.

[22]  J. Radford,et al.  An analysis of prognostic factors in stage III and IV Hodgkin's disease treated at a single centre with MVPP. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  P. Biberfeld,et al.  Prognostic factors in hodgkin's disease with special reference to age , 1984, Cancer.

[24]  T. Hakulinen,et al.  Cancer survival corrected for heterogeneity in patient withdrawal. , 1982, Biometrics.

[25]  P. Trott,et al.  International Classification of Diseases for Oncology , 1977 .

[26]  J. Holý,et al.  [Epidemiology of Hodgkin's disease]. , 1977, Ceskoslovenska pediatrie.

[27]  V. Devita,et al.  Combination chemotherapy in the treatment of advanced Hodgkin's disease. , 1970, Annals of internal medicine.

[28]  J. Gough.  Hodgkin's disease; a correlation of histopathology with survival. , 1970, International journal of cancer.

[29]  R. Lukes,et al.  Correlation of histopathology with other prognostic indicators in Hodgkin's disease , 1968, Cancer.

[30]  R. Lukes,et al.  Natural history of Hodgkin's disease as related to its pathologic picture , 1966 .